KEGG enrichment pathway chart (bubble chart) (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal group (C) Severe PTOA group VS normal group. by Peng-fei Han (694841)

Tourism determinants’ marginal effects. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Descriptive statistics from 2005 to 2018. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Models 7 to 12: estimation results. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Models 1 to 6: estimation results. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Hausman test results. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Variable’s construction. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Moran’s I across countries. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Raw dataset. by Sakar Hasan Hamza (20978818)

“…In comparison, a similar rise in neighboring countries’ prices leads to a 0.4 percent decrease in inbound tourists. …”

Multiomics Approach Identifies Key Proteins and Regulatory Pathways in Colorectal Cancer by Jun Rao (2031019)

“…Notably, vesicle-associated membrane protein-associated protein A (VAPA) was found to be consistently and significantly decreased in most types of CRC samples, and its level was also significantly correlated with increased overall survival of CRC patients. …”

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Narrow- and broad-band spectral changes after hemispherotomy in an awake representative patient, displaying marked electroencephalography (EEG) slowing of the isolated cortex. by Michele Angelo Colombo (22446342)

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

“…<div><p>Introduction</p><p>Traumatic brain injury (TBI) is a major cause morbidity and mortality globally. …”

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

“…<div><p>Introduction</p><p>Traumatic brain injury (TBI) is a major cause morbidity and mortality globally. …”

All infection data from the study. by Hala Tamim El Jarkass (16625309)

“…We show that infection causes an increase in the level of <i>C. elegans</i> lipid droplet associated lipase, ATGL-1, and a decrease in host fat levels. …”

Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D. by Lorenza Cutrone (21144285)

Prime sequences. by Qiaozhen Qin (13159201)

“…Micro RNAs (miRNAs) have been revealed to participate in the pathological process of depression and represent promising therapeutic targets. In this study, we found that microRNA-129-5p (miR-129-5p) was significantly decreased in the brains of depressive mice. …”

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)